Journals / İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi / 2013 / Cilt: 3 - Sayı: 3

Evaluation of myocardial functions in children receiving anthracyclines

Antrasiklin uygulanmış çocuk hastaların miyokardiyal performanslarının değerlendirilmesi

Pages
191–197
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We suggest that RV and LV tissue MPI be primarily used in the search for anthracycline cardiotoxicity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In our study, using echocardiographic measurements, patients with acute lymphob - lastic leukemia receiving anthracycline therapy have been evaluated as for the presence of anthracycline-induced cardiac dysfunction, and it has been carried out to determine the statis- tically significant predictive echocardiographic parameters.
📊
Key Findings & Data:Methods: Thirty cases (mean age 9.87±3.92 years, 13 males and 17 females) with acute lymphob - lastic leukemia receiving anthracycline therapy were enrolled in the study, along with 30 age- matched controls.
💡
Conclusion & Impact:We suggest that RV and LV tissue MPI be primarily used in the search for anthracycline cardiotoxicity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In our study, using echocardiographic measurements, patients with acute lymphob - lastic leukemia receiving anthracycline therapy have been evaluated as for the presence of anthracycline-induced cardiac dysfunction, and it has been carried out to determine the statis- tically significant predictive echocardiographic parameters. Methods: Thirty cases (mean age 9.87±3.92 years, 13 males and 17 females) with acute lymphob - lastic leukemia receiving anthracycline therapy were enrolled in the study, along with 30 age- matched controls. Their cardiac functions were evaluated echocardiographically with two dimensional, M-mode, PW Doppler and PW tissue Doppler methods. Results: Left ventricular cardiac functions were significantly reduced in the study group. The fractional shortening (FS) was 36.09±3.17 in the study group as opposed to 39.65±3.21 in cont- rols (p=0.03). Diastolic functions (E/A ratio) weren’t significantly altered in the study group. Right ventricular (RV) flow E/A was 1.36±0.29 and 1.34±0.69, respectively (p>0.05). Left vent- ricular (LV) flow E/A was 1.53±0.31 and 1.58±0.35, respectively (p>0.05). Myocardial perfor- mance index (MPI) was calculated in the study subjects using both PW Doppler and PW tissue Doppler methods, and compared to controls. RV flow MPI was 0.39±0.02, and 0.33±0.03, res- pectively (p<0.01). LV flow MPI was 0.41±0.08 and 0.34±0.04, respectively (p<0.01). RV tissue MPI was 0.44±0.04, and 0.39±0.05, respectively (p<0.01). LV tissue MPI was 0.42±0.02 and 0.36±0.01, respectively (p<0.01). Conclusion: The results of our study show that MPI and systolic functional changes are better indicators of anthracycline cardiotoxicity than diastolic functions. We suggest that RV and LV tissue MPI be primarily used in the search for anthracycline cardiotoxicity.

Özet

Amaç: Çalışmamızda antrasiklin tedavisi almış akut lenfoblastik lösemili (ALL) hastalar ekokar- diyografik ölçümler kullanılarak antrasiklin kardiyotoksisitesi açısından değerlendirilmiş ve kardiyotoksisiteyi istatistiksel olarak anlamlı gösteren ekokardiyografik parametreler belirlenmiştir. Yöntemler: Çalışmaya antrasiklin tedavisi almış akut lenfoblastik lösemili 30 (ortalama 9.87±3.92 yaş, 13’ü erkek, 17’si kız) hasta ile, aynı yaş gurubundan 30 sağlıklı çocuk alındı. Kardiyak fonksiyonları ekokardiyografik olarak iki boyutlu, M-mode, PW Doppler ve PW doku Doppler yöntemleri ile değerlendirildi. Bulgular: Hasta grubunun sol ventrikül kısalma fraksiyonda (KF) kontrol grubuna göre belirgin azalma saptandı (36.09±3.17 ve 39.65±3.21, p=0.03). Hasta grubunun diyastolik fonksiyonlarında ise kontrol grubuna göre hem akım hem de doku Doppler ile değişiklik saptanmadı. Sağ ventrikül (Sağ V) akım E/A hasta grubunda 1.36±0.29, kontrol grubunda 1.34±0.69 (p>0.05), Sol ventrikül (Sol V) akım E/A hasta grubunda 1.53±0,31, kontrol grubunda 1.58±0,35 (p>0.05) idi. Miyokardiyal performans indeksi (MPİ) hasta grubunda PW doppler ve PW doku doppler yön - temi kullanılarak hesaplandı ve kontrol grubuyla karşılaştırıldı. Sağ V akım MPİ 0.39±0.02 ve 0.33±0.03 (p<0.01). Sol V akım MPİ 0.41±0.08 ve 0.34±0.04 (p<0.01). Sağ V doku MPİ 0.44±0.04 ve 0.39±0.05 (p<0.01). Sol V doku MPİ 0.42±0,02 ve 0.36±0.01 (p<0.01). Sonuç: Çalışmamızın sonuçları antrasiklin kardiyotoksisitesini belirlemede MPİ ve sistolik fonksiyonlardaki değişimin, diyastolik fonksiyonlara göre daha iyi birer gösterge olduğunu göstermiştir. Sağ ve Sol V doku MPİ antrasikline bağlı geç kardiyotoksisiteyi göstermede öncellikli olarak kullanılabilir olduğunu düşünüyoruz.

🔖

Cite This Article

YOZGAT, Y., OKUTAN, V., KÜREKÇİ, A. E., ATAY, A. A., KARAARSLAN, U., LENK, M. K., ÖZCAN, O. (2013). Evaluation of myocardial functions in children receiving anthracyclines. İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi, Cilt: 3 - Sayı: 3, 191–197. https://ajindex.com/articles/214937

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Riccardi R, Lasorella A, Mastrangelo R. Principles of cancer chemotherapy in children. In: Cancer in children. 4 th edition, (Eds) Voute PA, Kalifa C, Barrett A. Oxford Med Public: 1998, 44-59
  2. Schimmel KJ, Richel DJ, van den Brink RB, Guchelaar HJ. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev 2004;30(2):181-91. http://dx.doi.org/10.1016/j.ctrv.2003.07.003 PMid:15023436 3. Jain D. Cardiotoxicity of doxorubicin and other anthracycline derivatives. Nucl Cardiol 2000;7(1):53-62. http://dx.doi.org/10.1067/mnc.2000.103324 PMid:10698235 4. Scully SE, Lipshultz SE. Anthracycline cardiotoxicity in long-term survivors of childhood cancer. Cardiovasc Toxicol 2007;7(2):122-128. http://dx.doi.org/10.1007/s12012-007-0006-4 PMid:17652816 5. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB. New index of combined systolic and diastolic myocardial performance: a simple and reprodu - cible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 1995;26(6):357-66. PMid:8558414 6. Öcal B, Oğuz D, Karademir S, Birgen D, Yüksek N, Ertem U, et al. Myocardial performance index combining systolic and diastolic myocardial performance in doxorubicin-treated patients and its correlation to conventional echo/Doopler indices. Pediatr Cardiol 2002;23(5):522-7. PMid:12211201 7. Yildirim A, Tunaoğlu FS, Pinarli FG, Ilhan M, Oğuz A, Karadeniz C et al. Tissue and flow myocardial performance index measurements taken during dobutamine stres echocar- diography for early diagnosis of late anthracycline cardioto - xicity. Pediatr Cardiol 2010;31(1):96-105. http://dx.doi.org/10.1007/s00246-009-9579-y PMid:19937012 8. Xu XY, Huang MR, Tang JY, Zhang YQ, WuYR, Zhou M. Evaluation of early monitoring of cardiotoxicity induced by anthracyclines. Chinese Journal of Contemporary Pediatrics 2011;13(6):490-494. PMid:21672425 9. İshii M, Tsutsumi T, Himeno W, Eto G, Furui J et al. Sequential evaluation of left ventricular myocardial perfor- mance in children after anthracycline therapy. Am J Cardiol 2000;86(11):1279-1281.
  3. Sahn DJ, De Maria A, Kisslo J, Weyman A. The committee an M-mode standardisation of the American Society of Echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58(6):1072-1083. http://dx.doi.org/10.1161/01.CIR.58.6.1072 PMid:709763 11. Eidem BW, O’Leary PW, Tei C, Seward JB. Usefulness of the myocardial performance index for ases